Insider · CIK 0001542073

He Wei-Wu

Reports to the SEC for 2 companies · BEIJING

sec.gov

Transactions

Companies

Filings

CIK

0001542073

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-06-15	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+50K sh	$3.18	+$159K	644,553
2022-06-14	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+2,096 sh	$3.06	+$6,413.76	594,553
2022-06-13	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+36.1K sh	$2.97	+$107K	592,457
2021-11-18	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+200K sh	$0.98	+$196K	5,558,472
2021-11-17	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+200K sh	$0.99	+$198K	5,362,569
2021-08-19	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+180K sh	$1.26	+$227K	5,163,994
2021-08-18	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+300K sh	$1.29	+$387K	4,983,994
2021-06-15	CASI Pharmaceuticals, Inc (DE)Stock Options (Right to Buy)A Award	Director, Chairman and CEO, 10% Owner	AAward	+4M sh	—	—	4,000,000
2021-03-26	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+3M sh	$2.05	+$6.15M	3,000,000
2020-12-22	CASI Pharmaceuticals, Inc (DE)G Gift	Director, Chairman and CEO, 10% Owner	GGift	−380K sh	—	—	4,683,994
2020-11-23	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+100K sh	$2.18	+$218K	5,063,994
2020-11-20	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+127K sh	$2.12	+$270K	4,963,994
2020-07-22	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+1.2M sh	$1.90	+$2.28M	7,532,347
2020-07-22	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+2.95M sh	$1.90	+$5.61M	4,836,523
2020-05-20	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+56.5K sh	$2.37	+$134K	1,884,097
2020-05-19	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+29.8K sh	$2.03	+$60.5K	1,827,663
2020-05-18	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+339K sh	$2.02	+$685K	1,797,832
2020-05-15	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+100K sh	$1.82	+$182K	1,458,900
2020-03-27	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+6,880 sh	$2.08	+$14.3K	1,358,900
2020-03-26	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+328K sh	$2.09	+$686K	1,352,020
2020-03-25	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+196K sh	$1.94	+$381K	1,023,925
2020-03-19	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+234K sh	$1.57	+$368K	6,332,347
2020-03-18	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+501K sh	$1.52	+$762K	6,097,859
2020-03-17	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+264K sh	$1.50	+$396K	5,596,537
2019-12-16	CASI Pharmaceuticals, Inc (DE)WarrantX Exercise of In-Money	Director, Chairman and CEO, 10% Owner	XExercise of In-Money	−374K sh	—	—	0
2019-12-16	CASI Pharmaceuticals, Inc (DE)X Exercise of In-Money	Director, Chairman and CEO, 10% Owner	XExercise of In-Money	+374K sh	$1.69	+$633K	5,332,345
2019-08-16	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+20K sh	$3.20	+$64K	827,527
2019-08-14	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+160K sh	$3.17	+$507K	807,527
2019-06-20	CASI Pharmaceuticals, Inc (DE)Stock Option (Right to Buy)A Award	Director, Chairman and CEO, 10% Owner	AAward	+4M sh	—	—	4,000,000
2018-12-19	CASI Pharmaceuticals, Inc (DE)G Gift	Director, Chairman and CEO, 10% Owner	GGift	−200K sh	—	—	647,527
2018-06-11	CASI Pharmaceuticals, Inc (DE)Stock Options (Right to Buy)A Award	Director, Chairman and CEO, 10% Owner	AAward	+1M sh	—	—	1,000,000
2018-03-19	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+3.09M sh	$3.24	+$10M	4,958,024
2018-03-19	CASI Pharmaceuticals, Inc (DE)Warrants (Right to Buy)A Award	Director, Chairman and CEO, 10% Owner	AAward	+1.23M sh	—	—	1,234,567
2017-10-10	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+100K sh	$1.95	+$195K	847,527
2017-10-06	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+100K sh	$1.86	+$186K	747,527
2017-10-05	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+100K sh	$1.80	+$180K	647,527
2017-09-19	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+34K sh	$1.78	+$60.5K	547,527
2017-09-18	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+174K sh	$1.75	+$304K	513,525
2017-09-15	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+128K sh	$1.49	+$190K	340,025
2017-09-14	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+188K sh	$1.22	+$229K	212,323
2017-06-08	CASI Pharmaceuticals, Inc (DE)Stock Options (Right to Buy)A Award	Director, Chairman and CEO, 10% Owner	AAward	+100K sh	—	—	100,000
2016-10-24	CASI Pharmaceuticals, Inc (DE)Stock Options (Right to Buy)A Award	Director, Chairman and CEO, 10% Owner	AAward	+202K sh	—	—	202,247
2016-10-03	CASI Pharmaceuticals, Inc (DE)P Purchase	Director, Chairman and CEO, 10% Owner	PPurchase	+1.87M sh	$1.19	+$2.23M	1,871,605
2016-10-03	CASI Pharmaceuticals, Inc (DE)Stock Options (Right to Buy)A Award	Director, Chairman and CEO, 10% Owner	AAward	+366K sh	—	—	366,343
2016-10-03	CASI Pharmaceuticals, Inc (DE)WarrantsA Award	Director, Chairman and CEO, 10% Owner	AAward	+374K sh	$0.03	+$9,358.025	374,321
2016-07-05	CASI Pharmaceuticals, Inc (DE)Stock Options (Right to Buy)A Award	Director, Chairman and CEO, 10% Owner	AAward	+84.5K sh	—	—	84,507
2016-06-24	CASI Pharmaceuticals, Inc (DE)Stock Options (Right to Buy)A Award	Director, Chairman and CEO, 10% Owner	AAward	+370K sh	—	—	369,805
2016-06-02	CASI Pharmaceuticals, Inc (DE)Stock Options (Right to Buy)A Award	Director, Chairman and CEO, 10% Owner	AAward	+712K sh	—	—	712,112
2016-03-02	CASI Pharmaceuticals, Inc (DE)Stock Options (Right to Buy)A Award	Director, Chairman and CEO, 10% Owner	AAward	+100K sh	—	—	100,000
2015-04-06	CASI Pharmaceuticals, Inc (DE)Stock Options (Right to Buy)A Award	Director, Chairman and CEO, 10% Owner	AAward	+100K sh	—	—	100,000

Recent filings

Accepted (ET)
Jun 174
He Wei-Wu0001104659-22-072392
SEC(opens sec.gov)
Nov 194
He Wei-Wu0001104659-21-141867
SEC(opens sec.gov)
Aug 204
He Wei-Wu0001104659-21-108182
SEC(opens sec.gov)
Jun 164
He Wei-Wu0001104659-21-081983
SEC(opens sec.gov)
Mar 304
He Wei-Wu0001104659-21-043957
SEC(opens sec.gov)
Dec 234
He Wei-Wu0001104659-20-139064
SEC(opens sec.gov)
Nov 244
He Wei-Wu0001104659-20-129106
SEC(opens sec.gov)
Jul 244
He Wei-Wu0001104659-20-086415
SEC(opens sec.gov)
May 214
He Wei-Wu0001104659-20-064841
SEC(opens sec.gov)
May 194
He Wei-Wu0001104659-20-063872
SEC(opens sec.gov)
Mar 304
He Wei-Wu0001104659-20-040338
SEC(opens sec.gov)
Mar 274
He Wei-Wu0001104659-20-039667
SEC(opens sec.gov)

Companies

Address

1701-1702, CHINA CENTRAL OFFICE TOWER 1, NO. 81 JIANGUO ROAD CHAOYANG DISTRICT

BEIJING, 100025